Compounds > granisetron

granisetron and Bone Neoplasms

granisetron has been researched along with Bone Neoplasms in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoki, Y; Hayashi, K; Higuchi, T; Igarashi, K; Inatani, H; Kato, T; Kimura, H; Nishida, H; Shimozaki, S; Shirai, T; Takeuchi, A; Tanzawa, Y; Tsuchiya, H; Yamamoto, N1
Chow, E; DeAngelis, C; Hunyh, L; McDonald, R; Pasetka, M; Raman, S; Rowbottom, L1
Caran, EM; Luisi, FA; Petrilli, AS; Tanaka, C1
Hashimoto, R; Ikeda, K; Kurokawa, N; Okamoto, Y; Takagi, T; Takenaka, M; Ueda, T; Uejima, E1
Arita, S; Chigira, M; Hasegawa, A; Shinozaki, T; Watanabe, H1
Bacci, G; Beghelli, C; Biolchini, A; Ferrari, S; Forni, C; Loro, L; Mazzei, T; Puggioli, C; Simoni, P; Strazzari, S; Tremosini, M1
Hunter, RD; Logue, JP; Magee, B; Murdoch, RD1

Trials

4 trial(s) available for granisetron and Bone Neoplasms

ArticleYear
Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-da
    Cancer medicine, 2015, Volume: 4, Issue:3

    Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Aprepitant; Bone Neoplasms; Cross-Over Studies; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Palonosetron; Quinuclidines; Sarcoma; Serotonin 5-HT3 Receptor Antagonists; Treatment Outcome; Vomiting; Young Adult

2015
Contribution to the treatment of nausea and emesis induced by chemotherapy in children and adolescents with osteosarcoma.
    Sao Paulo medical journal = Revista paulista de medicina, 2006, Mar-02, Volume: 124, Issue:2

    Topics: Adolescent; Antiemetics; Antineoplastic Agents; Bone Neoplasms; Child; Dimenhydrinate; Female; Granisetron; Humans; Male; Metoclopramide; Nausea; Osteosarcoma; Prospective Studies; Vomiting

2006
Granisetron, tropisetron, and ondansetron in the prevention of acute emesis induced by a combination of cisplatin-Adriamycin and by high-dose ifosfamide delivered in multiple-day continuous infusions.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2000, Volume: 8, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Doxorubicin; Drug Administration Schedule; Extremities; Female; Granisetron; Humans; Ifosfamide; Indoles; Male; Ondansetron; Osteosarcoma; Tropisetron; Vomiting

2000
The antiemetic effect of granisetron in lower hemibody radiotherapy.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1991, Volume: 3, Issue:5

    Topics: Aged; Antiemetics; Bone Neoplasms; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Prospective Studies; Radiotherapy; Vomiting

1991

Other Studies

3 other study(ies) available for granisetron and Bone Neoplasms

ArticleYear
Efficacy of granisetron and aprepitant in a patient who failed ondansetron in the prophylaxis of radiation induced nausea and vomiting: a case report.
    Annals of palliative medicine, 2015, Volume: 4, Issue:1

    Topics: Antiemetics; Aprepitant; Bone Neoplasms; Breast Neoplasms; Female; Granisetron; Humans; Middle Aged; Morpholines; Nausea; Neoplasm Metastasis; Ondansetron

2015
[Comparison of antiemetic efficacy of 5-HT3 receptor antagonists in orthopedics cancer patients receiving high-dose chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:3

    Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bone Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Granisetron; Humans; Ifosfamide; Male; Middle Aged; Nausea; Ondansetron; Osteosarcoma; Prospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting

2007
Possible cardiac side effects of granisetron, an antiemetic agent, in patients with bone and soft-tissue sarcomas receiving cytotoxic chemotherapy.
    Cancer chemotherapy and pharmacology, 1995, Volume: 35, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bradycardia; Chemotherapy, Adjuvant; Child; Electrocardiography; Female; Granisetron; Heart; Heart Block; Humans; Male; Sarcoma; Soft Tissue Neoplasms; Vagus Nerve; Vomiting

1995